160 related articles for article (PubMed ID: 23535315)
41. Clinical value of metabolic tumor volume by PET/CT in extranodal natural killer/T cell lymphoma.
Song MK; Chung JS; Shin HJ; Moon JH; Ahn JS; Lee HS; Lee SM; Lee GW; Kim SJ; Lee SM
Leuk Res; 2013 Jan; 37(1):58-63. PubMed ID: 23040533
[TBL] [Abstract][Full Text] [Related]
42. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
[TBL] [Abstract][Full Text] [Related]
43. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
44. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.
Wang L; Wang H; Li PF; Lu Y; Xia ZJ; Huang HQ; Zhang YJ
Ann Hematol; 2015 Aug; 94(8):1381-8. PubMed ID: 25865943
[TBL] [Abstract][Full Text] [Related]
45. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
[No Abstract] [Full Text] [Related]
46. Nasal NK/T-cell lymphoma: computed tomography and magnetic resonance imaging findings.
Ou CH; Chen CC; Ling JC; Chai JW; Wu CH; Chen WH; Hung HC; Tain-Lee ; Ho TL
J Chin Med Assoc; 2007 May; 70(5):207-12. PubMed ID: 17524998
[TBL] [Abstract][Full Text] [Related]
47. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
Kim SJ; Choi JY; Hyun SH; Ki CS; Oh D; Ahn YC; Ko YH; Choi S; Jung SH; Khong PL; Tang T; Yan X; Lim ST; Kwong YL; Kim WS;
Lancet Haematol; 2015 Feb; 2(2):e66-74. PubMed ID: 26687611
[TBL] [Abstract][Full Text] [Related]
48. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.
Kim TM; Park YH; Lee SY; Kim JH; Kim DW; Im SA; Kim TY; Kim CW; Heo DS; Bang YJ; Chang KH; Kim NK
Blood; 2005 Dec; 106(12):3785-90. PubMed ID: 16109779
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M
Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320
[TBL] [Abstract][Full Text] [Related]
50. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
Varelas AN; Ganti A; Eggerstedt M; Tajudeen BA
Laryngoscope; 2019 Dec; 129(12):2675-2680. PubMed ID: 30801751
[TBL] [Abstract][Full Text] [Related]
51. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH
Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120
[TBL] [Abstract][Full Text] [Related]
52. Short-Course Versus Long-Course Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study.
Li J; Li Y; Zhong M; Liu X; Song Y; Li J; Li K; Yi P
Med Sci Monit; 2018 May; 24():2683-2692. PubMed ID: 29712887
[TBL] [Abstract][Full Text] [Related]
53. A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment.
Chen Z; Fang X; Huang H; Wang Z; Hong H; Chen M; Ren Q; Yao Y; Zhang L; Tian Y; Lin S; Lin T
Ann Hematol; 2020 Dec; 99(12):2811-2819. PubMed ID: 32975588
[TBL] [Abstract][Full Text] [Related]
54. The extent of local tumor invasion predicts prognosis in stage IE nasal natural killer/T-cell lymphoma: a novel T staging system for risk stratification.
Bi XW; Zhang WW; Li ZM; Huang JJ; Xia Y; Sun P; Wang Y; Jiang WQ
Ann Hematol; 2015 Sep; 94(9):1515-24. PubMed ID: 25924921
[TBL] [Abstract][Full Text] [Related]
55. [Prognostic factors of nasal NK/T-cell lymphoma].
Ma Q; Zhang HL; Liu X; Zhou SY; Qian ZZ; Zhai QL; Fu K; Wang HQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 48(12):1011-6. PubMed ID: 24507001
[TBL] [Abstract][Full Text] [Related]
56. Extranodal natural killer/T-cell lymphoma nasal type: detection by computed tomography features.
Hsu YP; Chang PH; Lee TJ; Hung LY; Huang CC
Laryngoscope; 2014 Dec; 124(12):2670-5. PubMed ID: 25124693
[TBL] [Abstract][Full Text] [Related]
57. Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type.
Zhao T; Li YX; Wang SL; Jin J; Wang WH; Song YW; Liu YP; Liu XF; Fang H; Ren H; Chen B; Qi SN; Liu QF; Lu NN; Yu ZH
Ann Hematol; 2013 Mar; 92(3):325-32. PubMed ID: 23100164
[TBL] [Abstract][Full Text] [Related]
58. Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Yi PY; Li JW; Liu XL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Yao Y; Fan Z; Tang T; Jiang WQ
Oncotarget; 2017 Jan; 8(3):4245-4256. PubMed ID: 28002803
[TBL] [Abstract][Full Text] [Related]
59. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
[TBL] [Abstract][Full Text] [Related]
60. "Sandwich" Chemotherapy (CT) with Radiotherapy (RT) improves outcomes in patients with stage IE/IIE extranodal natural killer (NK)/T-cell Lymphomas.
Zhang J; Zhu MY; Wang L; Wang H; Wang WD; Geng QR; Lu Y
Asian Pac J Cancer Prev; 2013; 14(7):4061-6. PubMed ID: 23991953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
